Home » Topics » Disease categories and therapies » Ocular

Ocular
RSS

Final results presented from phase II Vitrase trial

Nov. 13, 1998

Significant antiinflammatory activity seen with loteprednol etabonate in cataract surgery setting

Nov. 5, 1998

Vitrase to be fast-tracked by FDA

Oct. 16, 1998

Long-acting fluorine-containing prostaglandins for ocular diseases

Oct. 7, 1998

Phase II trial commences of AG-3340 in AMD

Sep. 17, 1998

Phase II testing of ISV-205 begins for glaucoma

Sep. 14, 1998

Micrologix Biotech advances development of antimicrobial peptides for treatment of eye infections

Sep. 14, 1998

Troponin I blocks retinal angiogenesis in another animal model

Sep. 11, 1998

IND application for NeXstar antiangiogenesis drug approved by FDA

Sep. 4, 1998

PMA for KeraVision Ring accepted for filing

Sep. 3, 1998

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for April 10, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for April 7, 2026
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Orexin OX2 receptor agonists disclosed in Vertex Pharmaceuticals patent
BioWorld Science
Vertex Pharmaceuticals Inc. has patented new macrocyclic sulfonamide orexin OX2 receptor agonists potentially useful for the treatment of amyotrophic lateral...